Panbela Therapeutics, Inc. (PBLA)
| Previous Close | 0.3207 |
| Open | 0.3576 |
| Bid | 0.3488 x 0 |
| Ask | 0.3576 x 0 |
| Day's Range | 0.3250 - 0.3576 |
| 52 Week Range | 0.3000 - 38.0000 |
| Volume | |
| Avg. Volume | 7,410 |
| Market Cap | 1.693M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -34.5100 |
| Earnings Date | Nov 14, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswirePanbela Provides Business Update and Reports Q3 2024 Financial Results
MINNEAPOLIS, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the quarter ended September 30, 2024. As previously announced, management is hosting an earnings call today at 4:30 p.m. ET. Q3 2024 and Recent Highlights: Up to $12.0 million financing commitment secured from strategic i
- GlobeNewswire
Panbela to Host Third Quarter 2024 Earnings Conference Call on November 14, 2024
MINNEAPOLIS, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that it will host a conference call on November 14, 2024, at 4:30 PM Eastern Time to discuss results for its third quarter ended September 30, 2024. Conference Call InformationToll Free: 877-545-0320International: 973-528-0002Participant Access Code: 370494We
